JSPR- Jasper Therapeutics, Inc.

Name: Jasper Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Jasper Therapeutics, Inc. (JSPR) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. JSPR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Martell Ron	234.0K	$211.2K	-
Dir	Shizuru Judith Anne	156.9K	$141.6K	-
COO	Mahal Jeetinder Singh	90.0K	$81.2K	-
CFO	Cross Herb	90.0K	$81.2K	-
Other	Tucker Edwin Jonathan	90.0K	$81.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 23, 2021	Glazer Capital, LLC69	10% Owner	Sell	152,883	$9.92	$1,516,599.36	-7.3%	+0.2%	-74.5%
Apr 19, 2021	Glazer Capital, LLC69	10% Owner	Sell	2,060	$9.97	$20,538.20	-0.2%	-0.3%	-72.1%
Feb 22, 2021	Glazer Capital, LLC69	10% Owner	Sell	12,810	$10.46	$134,005.00	-0.4%	-	-
Feb 5, 2021	Glazer Capital, LLC69	10% Owner	Sell	212	$10.40	$2,204.80	-	-	-
Jan 14, 2021	Glazer Capital, LLC69	10% Owner	Sell	101	$10.40	$1,050.40	-	-	-
Jan 8, 2021	Glazer Capital, LLC69	10% Owner	Sell	10,000	$10.25	$102,500.00	-0.9%	-	-
Dec 30, 2020	Glazer Capital, LLC69	10% Owner	Sell	93	$10.25	$953.25	-	-	-
Dec 28, 2020	Glazer Capital, LLC69	10% Owner	Sell	20,000	$10.18	$203,500.00	-0.9%	-	-
Dec 15, 2020	Glazer Capital, LLC69	10% Owner	Sell	20,000	$10.10	$202,000.00	-0.6%	-	-
Dec 7, 2020	Glazer Capital, LLC69	10% Owner	Sell	12	$10.67	$128.08	-	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC